APA (7th ed.) Citation

ZH, X., J, C., Y, H., C, L., XL, W., DF, H., . . . WJ, Z. (2026). ERRα-KDM5C restrains STING enhancer activity to modulate type I interferon signaling in breast cancer progression. Cell death & disease, 17(1), 228. https://doi.org/10.1038/s41419-026-08499-2

Chicago Style (17th ed.) Citation

ZH, Xu, et al. "ERRα-KDM5C Restrains STING Enhancer Activity to Modulate Type I Interferon Signaling in Breast Cancer Progression." Cell Death & Disease 17, no. 1 (2026): 228. https://doi.org/10.1038/s41419-026-08499-2.

MLA (9th ed.) Citation

ZH, Xu, et al. "ERRα-KDM5C Restrains STING Enhancer Activity to Modulate Type I Interferon Signaling in Breast Cancer Progression." Cell Death & Disease, vol. 17, no. 1, 2026, p. 228, https://doi.org/10.1038/s41419-026-08499-2.